News
News
- Now Accepting Reservations for the Newly Named Hotel Effie Sandestin
08/06/2019 / 17:40 - GlobeNewswire - CHF Solutions, Inc. Announces 53 Percent Increase in Revenues for Second Quarter 2019 Over Previous Year and 38 Percent Increase from Q1 2019
08/06/2019 / 14:00 - GlobeNewswire - Oncternal Therapeutics Announces Opening of Randomized Phase 2 Study of Cirmtuzumab in Combination with Ibrutinib
08/06/2019 / 14:00 - GlobeNewswire - Aeglea BioTherapeutics Reports Second Quarter 2019 Financial Results and Corporate Highlights
08/06/2019 / 14:00 - GlobeNewswire - CytomX Therapeutics to Present at the 2019 Wedbush PacGrow Healthcare Conference
08/06/2019 / 14:00 - GlobeNewswire - Sanofi : Dupixent® (dupilumab) showed positive topline results in Phase 3 trial of children aged 6 to 11 years with severe atopic dermatitis
08/06/2019 / 07:05 - GlobeNewswire - Entera Bio Appoints Adam Gridley as Chief Executive Officer
08/05/2019 / 14:00 - GlobeNewswire - Kiniksa Pharmaceuticals Announces Collaboration with the Myocarditis Foundation for the Pericarditis Community
08/05/2019 / 13:30 - GlobeNewswire - Allakos Announces AK002 Met All Prespecified Primary and Secondary Endpoints in Phase 2 Randomized, Double-Blind, Placebo-Controlled Study in Patients with Eosinophilic Gastritis (EG) and/or Eosinophilic Gastroenteritis (EGE)
08/05/2019 / 13:00 - GlobeNewswire - Allogene Therapeutics Appoints Rafael G. Amado, M.D. as Executive Vice President of Research and Development and Chief Medical Officer
08/05/2019 / 12:00 - GlobeNewswire
Real-time